Sequential cetuximab/bevacizumab therapy is associated with improved outcomes in patients with wild‐type KRAS exon 2 metastatic colorectal cancer.
Saved in:
| Title: | Sequential cetuximab/bevacizumab therapy is associated with improved outcomes in patients with wild‐type KRAS exon 2 metastatic colorectal cancer. |
|---|---|
| Authors: | Hsu, Hung‐Chih1,2 (AUTHOR), Liu, Yu‐Chun2 (AUTHOR), Wang, Chuang‐Wei3,4 (AUTHOR), Chou, Wen-Chi1,2 (AUTHOR), Hsu, Yu-Jen2,5 (AUTHOR), Chiang, Jy-Ming2,5 (AUTHOR), Lin, Yung-Chang1,2 (AUTHOR), Yang, Tsai-Sheng1,2 (AUTHOR) a481124@cgmh.org.tw |
| Source: | Cancer Medicine. Jul2019, Vol. 8 Issue 7, p3437-3446. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 137268186 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Sequential cetuximab/bevacizumab therapy is associated with improved outcomes in patients with wild‐type KRAS exon 2 metastatic colorectal cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Hsu%2C+Hung‐Chih%22">Hsu, Hung‐Chih</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+Yu‐Chun%22">Liu, Yu‐Chun</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Chuang‐Wei%22">Wang, Chuang‐Wei</searchLink><relatesTo>3,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chou%2C+Wen-Chi%22">Chou, Wen-Chi</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hsu%2C+Yu-Jen%22">Hsu, Yu-Jen</searchLink><relatesTo>2,5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chiang%2C+Jy-Ming%22">Chiang, Jy-Ming</searchLink><relatesTo>2,5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lin%2C+Yung-Chang%22">Lin, Yung-Chang</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yang%2C+Tsai-Sheng%22">Yang, Tsai-Sheng</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> a481124@cgmh.org.tw</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Cancer+Medicine%22">Cancer Medicine</searchLink>. Jul2019, Vol. 8 Issue 7, p3437-3446. 10p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=137268186 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/cam4.2235 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 10 StartPage: 3437 Titles: – TitleFull: Sequential cetuximab/bevacizumab therapy is associated with improved outcomes in patients with wild‐type KRAS exon 2 metastatic colorectal cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hsu, Hung‐Chih – PersonEntity: Name: NameFull: Liu, Yu‐Chun – PersonEntity: Name: NameFull: Wang, Chuang‐Wei – PersonEntity: Name: NameFull: Chou, Wen-Chi – PersonEntity: Name: NameFull: Hsu, Yu-Jen – PersonEntity: Name: NameFull: Chiang, Jy-Ming – PersonEntity: Name: NameFull: Lin, Yung-Chang – PersonEntity: Name: NameFull: Yang, Tsai-Sheng IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: Jul2019 Type: published Y: 2019 Identifiers: – Type: issn-print Value: 20457634 Numbering: – Type: volume Value: 8 – Type: issue Value: 7 Titles: – TitleFull: Cancer Medicine Type: main |
| ResultId | 1 |